SCHEMBL3785494

SCHEMBL3785494

Fc1ccccc1Nc1cccc2c1nc(N1CNC=N1)c1cccn12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 3/20 0.43
CSNK2B P67870 3/20 0.43
CSNK2A1 P68400 3/20 0.43
PIM2 Q9P1W9 3/20 0.43
LCK P06239 1/20 0.34
MAPT P10636 3/20 0.34
LMNA P02545 2/20 0.34
TP53 P04637 2/20 0.34
HTR2A P28223 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CACNA1B Q00975 1/20 0.31
APBA1 Q02410 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
TTK P33981 1/20 0.31
POLB P06746 1/20 0.31
HTR3E A5X5Y0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3785491 0.81 PIM1 (0.53) PIM1CSNK2BCSNK2A1PIM2LCK
SCHEMBL3789561 0.70 CSNK2B (0.45) PIM1CSNK2BCSNK2A1PIM2LCK
SCHEMBL3788628 0.66 PIM1 (0.32) PIM1CSNK2BCSNK2A1PIM2
SCHEMBL3790221 0.65 CDC25B (0.44) PIM1CSNK2BCSNK2A1PIM2MAPT
SCHEMBL13057041 0.65 PIM1 (0.60) PIM1CSNK2BCSNK2A1PIM2LCK
SCHEMBL3789556 0.61 PIM1 (0.56) PIM1CSNK2BCSNK2A1PIM2LCK
SCHEMBL13056970 0.60 PIM1 (0.68) PIM1CSNK2BCSNK2A1PIM2LCK
SCHEMBL13056964 0.59 PIM1 (0.50) PIM1CSNK2BCSNK2A1PIM2LCK
SCHEMBL29793294 0.59 CXCL8 (0.55) MAPTKDM4EMEN1RAB9AKMT2A
SCHEMBL396120 0.59 CXCL8 (0.55) MAPTKDM4EMEN1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298302-A1 NOVEL PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298302-A1 NOVEL PROTEIN KINASE MODULATORS PIM2, PIM1, PIM3 PIM1 2/4885CSNK2B 91/4885CSNK2A1 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.